Activities, Bill Numbers and Titles
|
|
Client: Amgen Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $401.44
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Neutral
|
$0.00
|
N/A
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
01/24/2023 |
Ronald Mariano
|
House of Representatives (3rd Norfolk)
|
$200.00
|
04/11/2023 |
Michael Rodrigues
|
Senate (First Bristol and Plymouth)
|
$200.00
|
| | Total contributions |
$400.00
|
|